H.C. Wainwright analyst Edward White reiterated a Hold rating on Inhibikase Therapeutics (IKT – Research Report) today. The company’s shares ...

Following successful mining tests by U.S. consortia and pioneering environmental impact assessment by the National Oceanic and Atmospheric Administration (NOAA) in the Clarion Clipperton Zone (CCZ) in ...

New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial ...

On Friday, Jefferies initiated coverage on Inhibikase Therapeutics Inc (NASDAQ:IKT) shares with a Buy rating and set a price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Inhibikase Therapeutics, Inc. before investing. In this article, we go over a few ...

United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has showcased a series of game-changing innovations at Arab Health 2025, solidifying pivotal ...

A downtrend has been apparent in Inhibikase Therapeutics, Inc. (IKT) lately. While the stock has lost 15.4% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was ...